Osimertinib mesylate

본문 바로가기


Home > Product > Osimertinib mesylate
Selling leads
Osimertinib mesylate
Posting date : Aug 29, 2025
Membership
Free Member Scince Jun 27, 2025
FOB Price
detailed discussion
Min. Order Quantity
1
Supply Abillity
hundreds of kgs
Port
Shanghai Port
Payment Terms
detailed discussion
Package
Convenient package
Keyword :
Category
Contact
Lena
Selling Leads Detail
Company Info
 
Quick Detail
Place of Origin
China [CN]
Brand Name
Royal
Model Number
+86 15242851296
HS-CODE
-
Package & Delivery Lead Time
Package
Convenient package
Detailed Description

AZD9291(mesylate), also known as osimertinib mesylate, is indicated for the treatment of disease progression that occurred during or after previous treatment with epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (Tkis). And the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) who have been confirmed to have positive EGFRT790M mutation through testing.


ECROBOT CO., Ltd, Business Registration Number : 220-88-71747, CEO J.W.Park, TEL : +82-2-552-7676, E-mail : E-mail : Contact us
Address : (Hwanghwa B/D 11F, Yeoksam-dong)320, Gangnam-daero, Gangnam-gu, Seoul, South Korea
About Us Privacy Policy Terms of use Copyright © 2000-2026 ECROBOT.COM. All rights reserved.
Top